Gilead Sciences, Inc. (GILD)
152.50
+3.13
(+2.10%)
USD |
NASDAQ |
Feb 06, 16:00
152.25
-0.25
(-0.16%)
After-Hours: 20:00
Gilead Sciences Shareholders Equity (Quarterly) : 21.54B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 8.658B |
| Johnson & Johnson | -- |
| Eli Lilly & Co. | -- |
| Merck & Co., Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.53B |
| Total Liabilities (Quarterly) | 37.08B |
| Debt to Equity Ratio | 1.158 |
| Current Ratio | 1.453 |
| Net Debt Paydown Yield | -0.23% |